Maxilene (Lidocaine)

Lidocaine works by blocking voltage‑gated sodium channels on peripheral nerves, which prevents the initiation and propagation of nerve impulses. This interruption of signal transmission results in temporary loss of sensation and analgesia at the site where the product is applied.

The appropriate amount of Maxilene to apply is determined by the prescribing healthcare professional based on the size of the area to be treated, the condition being addressed, and patient‑specific factors. Patients should follow the prescriber’s instructions and not exceed the recommended surface area.

Maxilene is classified as pregnancy category B1, indicating that animal studies have not shown risk to the fetus and there are no adequate human studies. It may be used during pregnancy or lactation only if the potential benefit justifies any potential risk, and this decision should be made by a qualified healthcare provider.

To order Maxilene, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After receiving the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with other topical anesthetics such as benzocaine or prilocaine, lidocaine in Maxilene typically offers a faster onset of action and a well‑established safety profile. It provides effective surface anesthesia for a broad range of minor skin procedures, while the risk of allergic reactions is generally lower than with some ester‑type anesthetics.

Maxilene should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Ensure the container is tightly closed when not in use to maintain product stability and potency.

Maxilene is applied topically to clean, intact skin. A thin layer is spread over the affected area using a gloved fingertip or applicator, as directed by the prescriber. The product should be left in place for the recommended duration before removal or before proceeding with the intended procedure.

The most serious risks include systemic lidocaine toxicity, which can manifest as neurological symptoms (e.g., dizziness, seizures) or cardiac disturbances (e.g., arrhythmias). Severe allergic reactions such as anaphylaxis and rare cases of methemoglobinemia are also possible and require immediate medical attention.

Maxilene should not be used on patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, on broken or infected skin, or in individuals where the prescribed surface area exceeds safety limits. Caution is also advised for patients with significant cardiac, hepatic, or renal impairment.